The quantitative analysis of three action modes of volatile anesthetics on purple membrane  by Nakagawa, Tatsuo et al.
The quantitative analysis of three action modes of volatile anesthetics on
purple membrane
Tatsuo Nakagawa a;1, Toshiaki Hamanaka a;*, Shinya Nishimura b, Ichiro Uchida c,
Takashi Mashimo c, Yuji Kito d
a Division of Biophysical Engineering, Department of Systems and Human Science, Graduate School of Engineering Science,
Osaka University, Toyonaka 560-8531, Japan
b Intensive Care Unit, Osaka University Hospital, Suita, Osaka 565-0871, Japan
c Department of Anesthesiology, Osaka University Medical School, Suita, Osaka 565-0871, Japan
d TYK Laboratory for Photobiology, 55 Higashi-Minato, Yokata, Toyama 930-2243, Japan
Received 27 December 1999; received in revised form 23 May 2000; accepted 26 May 2000
Abstract
We quantitatively assessed the spectroscopic changes of purple membrane in relation to the concentrations of a volatile
anesthetic. As reported previously, volatile anesthetics show three modes of action on purple membrane. By using an
anesthetic for which the concentration in solution could be determined spectroscopically and by applying modified analytical
methods regarding the M-intermediate lifetime, we were able to clarify the quantitative relation between anesthetic
concentration and each mode of action, a relation which in the past has only been described qualitatively. We also
determined through the measurement of transient pH changes with pyranine that the proton pump efficiency per
photochemical cycle in an action mode induced with low concentrations of anesthetic does not change from that of the native
state. Moreover, we dynamically obtained the individual M3bacteriorhodopsin difference spectrum of each state at room
temperature using our flash photolysis system equipped with a wavelength-tunable dye laser. These results demonstrated
again that we should clearly distinguish different action modes of anesthetics according to their concentrations. ß 2000
Elsevier Science B.V. All rights reserved.
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1. Introduction
Anesthesia originates from the interaction between
biomembranes and anesthetic molecules. Non-specif-
ic actions have been supposed because of the struc-
tural variety of anesthetic molecules (all lipophilic
membrane perturbants including gases, hydrocar-
bons, halogenated hydrocarbons, ethers, halogenated
ethers and other organic solvents can be anesthetics
[1]) and/or the strong correlation between anesthetic
potency and its solubility in lipids. Recently, how-
ever, it has been shown that several proteins change
their activities at clinical concentrations of anes-
thetic, leading to a hypothesis attributing the speci¢c
actions of anesthetics to proteins [2]. Hot controversy
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continues to surround these two contrary hypothe-
ses.
We chose purple membrane (PM) as a good model
biomembrane for the study of the molecular mecha-
nism of anesthesia because it possesses the following
favorable characteristics. PM is extracted purely
from the cell membrane of halobacteria and contains
a sole protein, bacteriorhodopsin (BR), and several
types of lipids. The protein-to-lipid ratio is 3:1,
which is a very high protein density [3]. Even in
native PM, BR trimers form two-dimensional hexag-
onal lattices, resulting in the determination of three-
dimensional structure of a membrane protein in
atomic resolution [4]. BR is formed by seven hydro-
phobic K-helices with intervening hydrophilic loops.
In the center of BR, a retinal chromophore is cova-
lently bound to Lys-216 via an O-Schi¡ base. The
absorption of light triggers an isomerization of the
chromophore from an all-trans con¢guration to 13-
cis ; BR is then transformed into several spectro-
scopically characterized intermediates, K, L, M, N
and O, and then ¢nally returns to its original state.
This process is called the photochemical reaction
cycle, and BR transports one proton from the cyto-
plasmic side to the extracellular side in a single cycle.
The maximum wavelength of absorption (Vmax) of
each intermediate depends on the electrostatic envi-
ronments formed by amino acid residues around the
O-Schi¡ base and whether the O-Schi¡ base is proton-
ated or not. The Vmax of the M-intermediates is at a
much shorter wavelength than the other intermedi-
ates as its Schi¡ base is deprotonated, which means
the M-intermediates are on the main stage of the
proton pumping.
It is expected that the investigation of anesthetic
actions on PM based on structural, functional and
spectroscopic information as mentioned above may
give us important suggestions to elucidate the mech-
anism of anesthesia at the atomic level. The interac-
tion between PM and volatile anesthetics was ¢rst
studied by Nishimura et al. [5] and was then inves-
tigated in detail by Uruga et al. [6]. There are three
di¡erent modes of action on PM depending on the
concentration of the volatile anesthetic. For low con-
centrations of anesthetic, the Vmax shifts from the 569
nm of the native PM to 567 nm, the decay of the M-
intermediate becomes fast, the e⁄ciency of the pro-
ton pump is enhanced, and PM retains its crystallin-
ity. We name the BR in this state BR567 and this
mode of anesthetic action mode I. Making use of the
maintenance of this crystallinity, we showed by X-
ray di¡raction experiments that volatile anesthetic
molecules bind to the protein^lipid interfacial region
near the surface of the membrane [7]. For higher
concentrations of anesthetic, the Vmax shows a large
blue shift to 480 nm, the M-intermediate lives longer,
BR loses its proton pump function [6,8], and PM is
no longer a crystal. We name this state BR480 and
this mode of action mode II. Furthermore, several
volatile anesthetics changed the Vmax to 380 nm (sim-
ilarly, BR380 and mode III) [5,9].
Other investigators who are studying interactions
between anesthetics and PM, however, have hardly
studied BR567/mode I because the di¡erence be-
tween the native state and BR567 is small and the
concentration range where mode I can be seen is
narrow. As there is a possibility that mode I is re-
lated to clinical anesthesia, however, it is desirable to
quantitatively determine the characteristics of mode
I. If we could determine the dependence of the quan-
tity of BR567 on the anesthetic concentration, the
distinct characteristics of mode II is expected to be
determined more clearly.
The purpose of this study was to determine the
quantitative relation between di¡erent action modes
of anesthetics and their concentrations. First, we ob-
served the absorption spectrum changes of PM de-
pending on the concentrations of four kinds of vol-
atile anesthetics, and examined whether BR567,
BR480 and BR380 were generated. We also tested
whether anesthetized PM is denatured by light irra-
diation in order to determine its suitability in laser
photolysis experiments. Next, to understand the pho-
tocycle of BR567 and BR480, we determined the
spectra of the M-intermediates of BR567 and
BR480 by performing polychromatic laser photolysis
experiments for pure BR567 and BR480 as well as
for a mixed sample of the two. Furthermore, we
determined the accurate ratio of native BR/BR567/
BR480 depending on the anesthetic concentration by
using a volatile anesthetic whose concentration could
be determined spectroscopically and by applying a
modi¢ed analytical method to M-intermediate decay
curves. We also used a pH indicator to test whether
the enhancement of the proton pump e⁄ciency in
BR567 reported by Uruga et al. [6] is due to a real
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enhancement of the e⁄ciency per photocycle or to a
shortening of the photocycle period. These experi-
ments were made possible by our laser photolysis
system equipped with a wavelength-tunable dye laser.
As a result, mode I is clearly distinguished from
mode II and mode III, and di¡erent actions and sites
of anesthetic molecules to biomembrane are strongly
suggested dependent on anesthetic concentrations.
2. Materials and methods
2.1. Sample preparation
Native PMs were isolated and puri¢ed according
to standard procedures [9]. The optical density (OD)
of the PMs was approximately 20, and they were
preserved at 4‡C after the addition of 20 mM
NaN3. We adjusted the pH, salt concentration,
and/or the concentration of the pH indicator, pyra-
nine, just before each experiment.
2.2. Chemicals
The volatile anesthetics chloroform, methoxy£ur-
ane (1,1-di£uoro-2,2-dichloroethyl methyl ether), and
sevo£urane (£uoromethyl-1,1,1,3,3,3-hexa£uoro-2-
propyl ether) were obtained from Wako Pure Chem-
ical Industries, Inc. (Osaka, Japan), Abbott Labora-
tories (trademark Penthrane; North Chicago, IL,
USA) and Maruishi Chemicals (Osaka, Japan), re-
spectively. These anesthetics are all well known clin-
ically. The concentrations of the anesthetics were cal-
culated by the amounts injected. We did not take
into account the concentration decrease due to the
partial evaporation of anesthetics during injections.
Tri£uoroethyl iodide (TI) was obtained from Al-
drich Chemical Co., Inc. (Milwaukee, WI, USA).
Rudo and Krantz [10] have reported that TI results
in stable anesthesia in monkeys; unfortunately, how-
ever, the anesthetic causes cardiac dysrhythmia in
man. We can quantify the concentration of TI in
solution by a spectrophotometer, for it has an ab-
sorption in the ultraviolet region (Vmax = 256 nm)
where the absorption of BR is small. Its value is so
large (ODs 5), however, under the present experi-
mental conditions that we actually used OD290. The
light scattering and the absorption of amino acid
residues with an aromatic ring, which might change
in the process of BR480 production, also relate to
OD290. Their contributions to the absorbance change
are, however, so small (6 0.03 when OD569 of PM is
V0.1) compared to the change of OD290 by the ad-
dition of TI (V0.8 at maximum concentrations) that
the error of the concentration of TI is less than sev-
eral percent.
The laser dye Stilbene 420, Coumarine 2 and
Rhodamine 101 were purchased from Exiton, Inc.
(Dayton, OH, USA). Pyranine (8-hydroxypyrene-
1,3,6-trisulfonic acid, trisodium salt), a pH-sensitive
dye, was purchased from Molecular probes, Inc. (Eu-
gene, OR, USA).
2.3. Static absorption spectrum measurements
The absorption spectra of suspensions of native
and anesthetized PM were measured by UV/Vis spec-
trophotometer V560 (Jasco, Tokyo, Japan) under
thermal controls. We used Te£on- or glass-capped
quartz cells with a path length of 10 mm.
2.4. Laser photolysis experiments
Laser photolysis experiments were performed us-
ing the improved time-resolved multichannel spectro-
photometer system USP-500 (Unisoku Co., Ltd.,
Osaka, Japan). Fig. 1 shows the whole system. A
two-way transparent quartz cell was set into a cell
holder kept at the same temperature as the V560
spectrophotometer. The light source for the excita-
tion of the sample was a YAG laser second/third
harmonic or a compact tunable dye laser TSP-611
(Unisoku Co., Ltd.) pumped by the YAG laser Sure-
lite I (Continuum, Santa Clara, CA, USA). The laser
beams are polarized vertically and are set to be per-
pendicular to the monitor beam. For the monitor
beam, a 150 W xenon lamp was used with its inten-
sity properly reduced by an iris diaphragm. To avoid
exposure of the sample to extra wavelength light, a
color glass ¢lter, and/or an interference ¢lter were
inserted between the monitor light source and the
sample cell. After passing through the sample cell,
the monitor light was split into two beams, with
one directly entering the photomultiplier A and the
other streaming into the spectrometer. The spectrom-
eter had a path selection mirror at the exit, which
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could switch the direction of the light to photomul-
tiplier B or a multichannel sensor (400 nm/512 ch). A
notch ¢lter was used behind the cell when using a
YAG 532 nm light for excitations, and color glass
¢lters were used if the second-order di¡raction light
of the grating was not negligible.
The maximum capabilities of this system are 10 ns
and 1 ms sampling for monochromatic and poly-
chromatic measurement, respectively. In the present
monochromatic study, however, pseudo-log sampling
acquisitions were performed from 100 Ws to 2 s after
the excitation in order to record multiple compo-
nents of lifetimes of di¡erent orders. The measure-
ments were repeated, and the data were averaged.
Reaction curves were ¢tted by one to four compo-
nents of the exponential function by a non-linear
least square analysis program (Unisoku), and the
half-life (t1=2) and amplitude of each component
were then obtained. In the polychromatic measure-
ments, spectra from 300 nm to 700 nm were mea-
sured with 1 ms sampling. We also repeated the mea-
surement and averaged data for every wavelength
and every sampling time.
Before and after all laser photolysis experiments,
we measured the static absorption spectrum to check
that there was no denaturation.
2.5. Transient pH measurements
For the native PM and the PM containing pure
BR567 obtained by saturated sevo£urane (see be-
low), the transient pH changes induced by light ab-
sorption were obtained from the di¡erence in the
absorbance of pyranine between the bu¡ered and
the non-bu¡ered sample [11]. The conditions were
pH 7, 20‡C and 150 mM KCl. As for bu¡ered solu-
tion, 20 mM Tris was applied.
For both samples, the time courses of the absor-
bance changes were measured at 412 nm, the Vmax of
the M-intermediate, and at 455 nm, which is the Vmax
of pyranine and an isosbestic wavelength between the
M-intermediate and the ground state. To correct for
£uctuations in the excitation intensity, each data
point was normalized by the peak height of the
OD550 change, which was simultaneously monitored
by photomultiplier A.
3. Results
3.1. Absorption spectra of PM
Fig. 2 demonstrates the dependence of the spectral
changes of PM on the concentrations of anesthetics.
Di¡erences in potency could be seen between di¡er-
ent kinds of anesthetics. First, when chloroform was
applied up to 5 mM, the spectrum changed slightly,
and the Vmax shifted to a shorter wavelength, that is,
mode I was observed. Afterward up to 30 mM, the
spectra changed drastically to the form of BR480,
showing the action of mode II. When 50 mM chloro-
form was added, BR380/mode III was observed (Fig.
2a).
Methoxy£urane successively showed mode I and
mode II actions with increasing concentration. At
20 mM, BR480 was produced almost perfectly (Fig.
2b). Even at a saturated concentration, methoxy£ur-
ane did not act on PM in mode III. As this BR480
was not denatured by intense illumination, it could
be suitably used to observe the characteristics of pure
BR480 in laser photolysis experiments.
Fig. 1. Tunable dye laser equipped with a £ash photolysis sys-
tem. WP: 1/2 wave plate; BT: beam trap; CL: cylindrical lens;
L: lens; RM: re£ection mirror; DC: dye cell ; OC: output cou-
pler; M: mirror; OF: optical ¢ber; P: polarizer; F: ¢lter; BS:
beam splitter; IF: interference ¢lter; PS: path selection mirror;
MS: multichannel sensor; PM: photomultiplier.
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As sevo£urane induced only BR567 even at satu-
rated concentrations (Fig. 2c), it is considered to be
appropriate for observation of the characteristics of
pure BR567.
Like methoxy£urane, TI produced almost pure
BR480, but an exposure to room light led irreversi-
bly and gradually to the production of BR380 (Fig.
2d); therefore, a PM suspension containing high con-
centrations of TI (s 30 mM) does not appear to be
appropriate for laser photolysis experiments. In Fig.
3, the absorbance changes at 590 nm and 450 nm are
plotted against the concentrations of TI. The changes
were small at 5 mM where mode I was dominant,
and then large changes were induced by mode II. At
concentrations over 15 mM, however, the changes
slowed down, implying the process of BR567 to
BR480 is not a simple single transition.
3.2. BR3M di¡erence spectra of native PM
To determine the BR3M di¡erence spectra, we
performed a polychromatic time-resolved experiment
using our multichannel system (Fig. 1).
To obtain a pure spectrum from each state of BR,
it is desirable for none of the states to coexist with
other states or to be denatured by repetitive excita-
tions. As described above, pure BR567 is produced
by saturated sevo£urane, and pure BR480 by satu-
rated methoxy£urane, with none of these being de-
natured during the laser photolysis experiment. We
then measured the transient spectral changes in these
two samples and compared these spectra with that of
the native BR. Curve 1 in Fig. 4 shows the di¡erence
between the spectrum after 2 ms and the one ob-
tained before the excitation of native BR. The neg-
Fig. 2. The dependence of the absorption spectra of PM on the concentrations of four kinds of volatile anesthetics. 20‡C, 20 mM
phosphate, pH 6, 150 mM KCl. (a) Chloroform; curve 1: 0 mM; 2: 5 mM; 3: 15 mM; 4: 30 mM; 5: 40 mM. (b) Methoxy£urane;
curve 1: 0 mM; 2: 2 mM; 3: 5 mM; 4:20 mM. (c) Sevo£urane; curve 1: 0 mM; 2: 1 mM; 3: 10 mM. (d) TI; curve 1: 0 mM;
2: 5.6 mM; 3: 14 mM; 4: 32 mM; 5: 32 mM after exposure to room light. An irreversible generation of BR380 was observed. As
for the sample containing TI, the OD of PM was one-tenth that of other samples in order to quantify the concentration of TI in the
ultraviolet region where the absorption of PM is small.
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ative change in the longer wavelength region indi-
cates the depletion of the ground state upon light
excitation and the positive change in the shorter re-
gion shows the appearance of the M-intermediate.
The maximum wavelength is 412 nm. We call this
the native M (native BR) di¡erence spectrum. Curve
2 is the di¡erence spectrum for BR567 induced by
the saturated sevo£urane. The positive peak also has
its maximum at 412 nm, so we call this the M412
(BR567) di¡erence spectrum. We could not detect a
clear di¡erence between M412 (BR567) and native M
(native BR) except that there may be a slight shift of
the negative peak wavelength to the shorter one. In
the above two cases, the YAG laser second harmon-
ic, 532 nm, was applied as the excitation light. Curve
3 shows the di¡erence between the spectrum ob-
tained 10 ms after the excitation and that of the
ground state of BR480 obtained with saturated me-
thoxy£urane. The longer wavelength region indicates
BR480 depletion, whereas the shorter region indi-
cates M-intermediate generation. The maximum
wavelength is 365 nm, so we will call this M form
M365 and call the spectrum the M365 (BR480) dif-
ference spectrum. In this case, a 446 nm dye laser
pulse from Coumarine 2 was used for the excitation.
Next, we prepared a PM sample containing 5 mM
methoxy£urane where BR567 and BR480 coexisted
(see also Fig. 2b) and performed the same polychro-
matic experiment with di¡erent excitation wave-
lengths. When the sample was excited by the YAG
second harmonic, 532 nm, spectra with complex
shapes and time courses were obtained (Fig. 5a, solid
line). On the other hand, the excitation of the same
sample by 621 nm light from the dye Rhodamine 101
induced almost the same spectrum as the M412
(BR567) di¡erence spectrum (Fig. 5b, see also Fig.
4, curve 2) except for a small shoulder around 480
nm. In addition, the M-intermediate was quickly de-
pleted (see curve 2 in Fig. 5b). This means that only
BR567 could be excited selectively and M412
(BR567) has a short lifetime. In the same way, 424
nm light from the dye Stilbene 420 generated almost
the same spectrum as M365 (BR480) di¡erence spec-
trum (Fig. 5c, see also Fig. 4, curve 3) except for a
minor shoulder around 570 nm. The M-intermediate
was, moreover, slowly depleted (see Fig. 5c, curve 2).
This strongly suggests that only BR480 could be ex-
cited selectively and M365 (BR480) has a long life-
time. Interestingly, the summation of spectra shown
in Fig. 5b,c approximately produces the spectra
shown in Fig. 5a (the summation is shown as a dot-
ted line in Fig. 5a). This additivity means that the
photocycle of BR567 and that of BR480 are inde-
pendent of each other.
Fig. 3. The amounts of native BR and BR567 depending on
the concentration of TI were monitored by the absorbance at
590 nm (¢lled circle) and that of BR480 was monitored at 450
nm (open circle). 20‡C, pH 6, 150 mM KCl.
Fig. 4. The di¡erence between spectra before and after the exci-
tation. 20‡C, pH 6, 150 mM KCl. Curve 1: native BR. The
data before the excitation were subtracted from the data at 2 ms
after the excitation. The excitation wavelength was 532 nm.
Curve 2: BR567 (PM with saturated sevo£urane). The same
conditions as for 1. Curve 3: BR480. The data before the exci-
tation were subtracted from the data at 10 ms after the excita-
tion with a 446 nm £ash. Dotted lines in each pro¢le are inter-
polated by hand because the £ashlight was superimposed on
the data at the excitation wavelength.
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As for BR380, no spectrum changes were seen
even when it was excited by the 355 nm YAG laser
third harmonic (data not shown). These results indi-
cate that the photochemical cycle is lost in BR380,
which is consistent with the report by Mitaku et al.
[8] that the retinal chromophore is free from protein
in the state of BR380.
3.3. M-intermediate decay time
We performed high signal-to-noise (S/N) mono-
chromatic laser photolysis experiments taking the
following points into account. The use of too large
an apparatus response time to smooth the noise or a
too intense excitation/monitor light must be avoided
because these conditions often induce artifacts. We
therefore improved the S/N by reducing the optical
losses and increasing the data accumulations. We set
the excitation wavelength at 532 nm and the obser-
vation wavelength at 375 nm, points at which infor-
mation regarding both M412 and M365 could be
deduced. Additionally, an interference ¢lter of 375
nm was put in front of the sample cell to avoid
illumination by extra wavelength light. Because its
precise concentration could be determined spectro-
scopically, TI was used as an anesthetic. Fig. 6a il-
lustrates the selected decay curves.
We can see that the decay time of the M-inter-
mediate gets faster at anesthetic concentration where
Fig. 5. The dependence of di¡erence absorption spectra on the
excitation wavelength. The sample was a PM suspension with
5 mM methoxy£urane where BR567 (by mode I) and BR480 (by
mode II) coexist. Other conditions are 20‡C, pH 6, 150 mM
KCl. The excitation wavelengths were (a) 532 nm (solid line),
(b) 621 nm, and (c) 424 nm. In each ¢gure, the spectra desig-
nated 1 were obtained as the di¡erence between the data at
1 ms after the excitation and the data obtained before the exci-
tation. Spectra 2 show the di¡erences between the data at 10 ms
after and before the excitation. Broken lines in (a) are the sum-
mation of the spectra in (b) and (c).
Fig. 6. (a) Transient absorbance changes of the M-intermediate
obtained by monochromatic laser photolysis. 20‡C, pH 6, 150
mM KCl. The excitation wavelength was 532 nm, and the ob-
servation wavelength was 375 nm. Curve 1: native PM; 2: PM
with 4.6 mM TI; 3: 11 mM TI; 4: 22 mM TI. 20‡C, pH 6. (b)
The ratios of each M-intermediate to the whole of M-intermedi-
ates depend on the concentration of TI. These ratios are ob-
tained from the amplitude of each component with a ¢xed life-
time calculated from the curves in (a). Also see the text. Open
circle: native M for which the lifetime (t1=2) is 2.6 ms; ¢lled
circle: M412 from BR567 with a lifetime of 1.2 ms; ¢lled and
open square: M365s from BR480 with lifetimes of 8 ms and
20 ms, respectively.
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BR567 is generated (Fig. 6a, curve 2), while slow
components appear at higher concentrations (Fig.
6a, curves 3,4), as reported for another volatile anes-
thetics [6,7].
At ¢rst, we treated both lifetime and amplitude as
parameters in the ¢tting analysis, similar to the pre-
vious analyses. The results are shown in Table 1. At
less than 9.2 mM, there is apparently a single com-
ponent and its lifetime get shorter gradually as the
anesthetic concentrations increase. At concentrations
over 9.2 mM, a double-exponential function showed
a good ¢t. We can see that shorter lifetimes are al-
most the same (V1.2 ms) in the concentration range
from 9.2 to 18.3 mM. As shown in Fig. 5b, this
component is attributed to M412 (BR567). Longer
lifetime is V7.5 ms at 9.2 mM and 11.0 mM, then
gets longer but comes to a constant value of 23 ms
over 14.0 mM. Fig. 5c shows that this component is
attributed to M365 (BR480). From the fact that al-
most constant values appeared for di¡erent anes-
thetic concentrations, we inferred that the M-inter-
mediate in each state, native M, M412 (BR567) and
M365 (BR480), has a ¢xed lifetime. As for the con-
centration of less than 9.2 mM, lifetimes vary from
2.60 ms to 1.75 ms, however, it is probable from the
above ¢nding that native M has a constant lifetime,
2.60 ms, and M412 (BR567) has a lifetime of approx-
imately 1.20 ms, independent of the anesthetic con-
centration. Because 2.60 ms and 1.20 ms are too
close to be distinguished in multi-exponential ¢tting
analysis, the change in the ratio of native M/M412
(BR567) is considered to result in the observation of
a single component with variable lifetimes.
We therefore performed a revised ¢tting analysis in
which the ratio of each state was treated as a param-
eter while the lifetime of each state was ¢xed regard-
less of the anesthetic concentration. From this anal-
ysis, we could deduce an accurate relation between
the anesthetic concentration and the ratios of native
BR/BR567/BR480.
If we assumed that there are four components, i.e.,
t1=2 = 2.6 ms for native M, 1.2 ms for M412 (BR567),
8 ms and 20 ms for M365 (BR480), respectively,
we succeeded in achieving a good ¢t over the entire
range of anesthetic concentrations only by altering
the ratio of their amplitudes. The ratios were cor-
rected for di¡erences in absorbance at the excita-
tion and observation wavelengths estimated from
Figs. 2 and 4, respectively, and then plotted in
Fig. 6b.
We previously reported a plot similar to Fig. 2b
[12], but the more sophisticated present analysis gives
us several new ¢ndings. The ratio of native M de-
creases slowly up to 10 mM, and M412 (BR567)
increases instead. Though M412 (BR567) decreases
drastically afterwards, it remains over 20 mM. M365
(BR480) appears as a component with an 8 ms life-
time at ¢rst, but another component with a 20 ms
lifetime becomes dominant immediately. When we
compare Fig. 6b with Fig. 3, the concentration re-
gion where the component with the 8 ms lifetime is
seen (7^14 mM) corresponds to the region where
dramatic amounts of BR480 are generated. On the
other hand, the component with the 20 ms lifetime
appears where the transition to BR480 slows down.
If we plot the summation of the quantities of native
M and M412 (BR567) versus the concentration of
TI, it is well consistent with the curve of OD590 in
Fig. 3. Similarly, the plot of the summation of two
components of M365 is well consistent with the curve
of OD450 in Fig. 3.
3.4. Transient pH changes and proton pump e⁄ciency
As mentioned above, sevo£urane induced only
BR567 by action of mode I even at saturated con-
centration (Fig. 2c). So we could get pure BR567 by
saturated sevo£urane. In Fig. 7 the rises and decays
of the M-intermediates (upper traces) and pH
changes (lower traces) are shown for native BR in
the absence of anesthetics (solid lines) and for BR567
Table 1
Calculated lifetimes and amplitudes (in parentheses) when both
are treated as parameters in non-linear least square ¢tting anal-
yses
[TI] (mM) Lifetime 1 (ms) Lifetime 2 (ms)
0 2.60 (100%) ^
2.4 2.30 (100%) ^
4.7 1.91 (100%) ^
7.1 1.75 (100%) ^
9.2 1.20 (83%) 7.17 (17%)
11.0 1.08 (78%) 7.68 (22%)
12.8 1.19 (75%) 15.9 (25%)
14.0 1.16 (55%) 23.3 (45%)
16.1 1.15 (46%) 24.1 (54%)
18.3 1.23 (39%) 22.9 (61%)
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in the presence of saturated sevo£urane (dotted
lines), respectively. The M-intermediate decay time
for BR567, 2.2 ms, is smaller than that for native
BR, 3.1 ms (these lifetimes are di¡erent from the
above ones due to the di¡erence in pH), while both
decay times of pH changes are almost the same.
There are £at regions in the pH curves, so the peak
height of the pH transient curve normalized by the
height of the M-intermediate absorbance curve gives
the proton pump e⁄ciency per photochemical cycle.
We can see, from Fig. 7, the normalized height was
almost the same in the cases of native BR (solid
lines) and BR567 (dotted line).
Previously, Uruga et al. [6] prepared a vesicle con-
taining BR oriented preferentially and measured the
pH change under continuous illumination using a pH
electrode; their results suggest that the proton pump-
ing e⁄ciency is enhanced in BR567. In the present
experiment, the decay time of the M-intermediate of
BR567 becomes faster than that of native BR, and
also the recovery of OD550, which corresponds to the
regeneration of the initial state, becomes faster from
4.0 ms to 3.1 ms (data not shown). This means that
BR567 has a shortened photochemical cycle. There-
fore, we conclude that the proton pump e⁄ciency
does not change in a single photochemical cycle
when BR is transformed to BR567 in response to
anesthetic, but the period of the cycle is shortened.
4. Discussion
Concerning the interaction between PM and anes-
thetic molecules, most investigators have paid more
attention to BR480 (mode II) and BR380 (mode III),
rarely even referring to BR567 (mode I) despite
BR567 being clearly distinguishable from native BR
and BR480 in terms of the proton pump e⁄ciency
(in the case of vesicles containing BR molecules),
crystallinity, and lifetime of the M-intermediate [6].
In the present study, we con¢rmed three states of BR
which are dependent on the concentration of anes-
thetics, and we also deduced the quantitative relation
between the anesthetic concentration and the ratio of
native M (native BR)/M412 (BR567)/M365 (BR480).
The marked change in the ratio of M412 (BR567)
versus anesthetic concentration shown in Fig. 6b is
particularly noteworthy. Native M (native BR) no
longer exists over 12 mM of TI, and M412
(BR567) is still present at rather high concentrations
(V20 mM). Therefore, a sample with s 12 mM of
TI is a mixture of BR480 and BR567, not native BR.
The selective excitation of BR567 by wavelengths
longer than 600 nm where BR480 has little absorp-
tion is e¡ective, if not perfect, in extracting informa-
tion about the photocycle of BR567 (Fig. 5b). Sim-
ilarly, information about the photocycle of BR480
can be e¡ectively obtained from the selective excita-
tion by wavelengths shorter than 450 nm (Fig. 5c).
From Fig. 5, the M-intermediate with a short lifetime
was identi¢ed as M412 (BR567) and the M-inter-
mediate with a long lifetime was identi¢ed as M365
(BR480). Furthermore, it was proved that each pho-
tocycle is not a¡ected by other photocycles from the
correspondence between the spectra obtained by the
simultaneous excitation of dual components (Fig. 5a,
solid line) and the calculated spectra obtained by the
summation of spectra measured by the selective ex-
citation of single components (Fig. 5a, dotted line).
Boucher et al. [13] have reported the BR3M di¡er-
ence spectra from a mixture of BR480 and BR567 by
static low temperature spectroscopic methods using
selective excitations through interference ¢lters. Our
data are consistent with theirs, and moreover, our
Fig. 7. Upper traces are the transient absorbance changes at
V= 412 nm, showing the rise and decay of the M-intermediate.
Lower traces show the transient pH changes calculated from
the absorbance di¡erence at V= 455 nm between the bu¡ered
and non-bu¡ered samples containing the pH indicator pyranine.
Solid line: native BR; dotted line: BR567 (PM with saturated
sevo£urane). 20‡C, 20 mM Tris, pH 7, 150 mM KCl. The hori-
zontal axis is the logarithmic scale.
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obtained spectra are much clearer than theirs in the
points of the separation of di¡erent components and
the transient property of each component, as the
result of more e¡ective excitation of BR480 or
BR567 by a tunable dye laser and the dynamic mea-
surements performed at room temperature.
In addition, the C50 value, the concentration giving
a 50% response, can be obtained from Fig. 6b. The
C50 value in mode I of TI for PM is estimated to be
approximately 6 mM. By comparing with the spectra
in Fig. 2, the C50 value for methoxy£urane and
chloroform can also be estimated at V2 mM and
V5 mM, respectively. On the other hand, the ED50
values, which are the concentrations that cause a loss
of the righting re£ex, are typically V0.33 mM for
methoxy£urane and V1 mM for chloroform, several
times smaller than the above C50 values. It has re-
cently been reported that some proteins, for example
GABAA receptor [14], alter their function at clinical
concentrations of anesthetics, and they are consid-
ered to be candidates for targets of anesthetics by
many investigators. We believe, however, that anes-
thesia is not caused by a change in a single speci¢c
protein function but is instead a result of ampli¢ca-
tion by multiple synaptic networks. Ueda and Ka-
maya [1] have discussed the e¡ects of anesthetics on
synaptic transmission reporting that a 10% inhibition
of each synapse would result in a 65% reduction in
the central neuronal system. Therefore, the C50 value
for a single protein is considered to be meaningful
when it does not deviate largely from the clinical
concentration. Thus, we can consider the possibility
that the same action as mode I in PM occurs gener-
ally in anesthesia.
We have previously reported that, in mode I, anes-
thetic molecules bind to the protein^lipid interface
near the surface of PM based on X-ray di¡raction
experiments with heavy atoms containing the anes-
thetic molecule diiodomethane [7]. TI also contains a
heavy iodine atom, and X-ray di¡raction experi-
ments show the same binding position as that found
in diiodomethane [12]. As the environment near the
surface of the membrane is hydrophilic, we think
that the breaking of hydrogen bonds on the surface
by anesthetic molecules slightly alters the state of
BR. The capacity of anesthetics to break hydrogen
bonds has been described theoretically by Sandorfy
[15]. Recently, the relation between the proton pump
and the network of hydrogen bonds in the BR pro-
ton pathway has been explained in detail [16]. As
Fig. 7 suggests, the proton pump e⁄ciency per pho-
tochemical cycle does not change, but the velocity of
the reaction increases; it is therefore considered that
breaking hydrogen bonds on the surface a¡ects the
state of this hydrogen bond network, resulting in a
slight rearrangement of amino acid residues near the
Schi¡ base.
With regard to mode II, we could obtain interest-
ing features of BR480 production in response to
anesthetic concentration. In Figs. 3 and 6b, we can
see that there is little production of BR480 or M365
at less than several mM of TI, thereafter it is pro-
duced drastically. We consider this sigmoidal charac-
teristic is attributed not to cooperative binding of
anesthetics to BR molecules but to the suppression
of the BR480 production by the existence of BR567.
As for this point and the fact that the transition from
BR567 to BR480 is biphasic, however, details are
future subjects.
In the present and previous studies, however, all of
the volatile anesthetics [5^7,17,18] and local anes-
thetics [19] except for sevo£urane have been shown
to induce BR480. Moreover, Uruga et al. [6] have
shown that sevo£urane also induces BR480 in recon-
stituted PM in which the ratio of lipids to proteins is
V100. It is therefore thought that mode II may rep-
resent the general action of anesthetics. Uruga et al.
[6] have shown by an X-ray di¡raction experiment
that PM containing BR480 loses its crystalline order,
and Hamanaka et al. [12] have suggested based on a
model calculation that anesthetic molecules enter
into the internal domain of membranes. The changes
in the potency of sevo£urane according to the pro-
tein/lipid ratio described above suggest that, in mode
II, anesthetic molecules do not enter the protein in-
terior but instead enter the hydrophobic lipid core.
Therefore, the large change in Vmax seen in BR480 is
due to an allosteric change in the internal structure
of BR through the action of anesthetics on the hy-
drophobic exterior region of proteins.
Finally, with regard to mode III, the suspension
containing BR380 had the same Vmax as the free all-
trans retinal chromophore. This result is consistent
with previously reported results [8] suggesting that
the retinal chromophore loses the Schi¡ base bond
with BR and that BR does not have a photochemical
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cycle. The results of our di¡raction experiment sug-
gest that BR380 exists as a monomer (unpublished
data). As this state is observed only when organic
solvents or hydrocarbon-type volatile anesthetics
are used, it is considered that the hydrophobic re-
gions of anesthetic molecules enter deeply into pro-
teins, greatly changing the conformation. This state
is often irreversible, so we believe that it has no re-
lation to the mechanism of anesthesia.
Di¡erent action modes of anesthetics according to
their concentrations have been observed in other in-
vestigations. As for the protein-free membrane, it has
been reported that anesthetic molecules ¢rst adsorb
to the interface, then proceed into the lipid core,
[20,21]. Mode I and mode II are considered to cor-
respond to these two steps, respectively. The impor-
tant di¡erence is, however, that PM contains pro-
teins. We think that the existence of proteins at
high density in PM made mode I noticeable as shown
in the present study. Although no crucial conclusion
about the molecular mechanism of anesthesia can be
obtained from the present data and their interpreta-
tion, the elucidation of the quantitative relation be-
tween anesthetic concentration and each mode o¡ers
fundamental information.
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